Next Generation Sequencing Market Scope And Analysis

  • Report Code : TIPHE100000820
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Next Generation Sequencing (NGS) Market Scope, Growth, Size and Share by 2031

Buy Now

Next Generation Sequencing (NGS) Market Report Next Generation Sequencing (NGS) Market Size and Share Next Generation Sequencing (NGS) Market Scope and Analysis

Next Generation Sequencing (NGS) Market Report Scope

Report Attribute Details
Market size in 2023 US$ 10.00 Billion
Market Size by 2031 US$ 34.75 Billion
Global CAGR (2023 - 2031) 16.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Platforms
  • Services
  • Consumables
By Technology
  • Genome Sequencing
  • Exome Sequencing
  • Resequencing & Targeted Sequencing
By Application
  • Diagnostics
  • Drug Discovery
  • Precision Medicine
By End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • Qiagen N V
  • Beijing Genomics Institute
  • Perkinelmer Inc
  • F Hoffmann La Roche AG
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd
  • Macrogen Inc

    • Next Generation Sequencing (NGS) Market News and Recent Developments

    The Next Generation Sequencing (NGS) market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Next Generation Sequencing (NGS) market are listed below:

    • In March 2022, as per the Press Release by Thermo Fisher Scientific, CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer is launched, a next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for clinical laboratories, the fully validated system enables users to perform diagnostic testing and clinical research on a single instrument.
    • In October 2022, press released by Illumina Inc. stated that they have partnered with GenoScreen to accelerate progress to end tuberculosis (TB) worldwide. The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB (MDR-TB).

    Next Generation Sequencing (NGS) Market Report Coverage and Deliverables

    The “Next Generation Sequencing (NGS) Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Next Generation Sequencing (NGS) market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Next Generation Sequencing (NGS) market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Next Generation Sequencing (NGS) market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Next Generation Sequencing (NGS) market
    • Detailed company profiles